Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 391 across all filing types
Latest filing 2019-12-13 Regulatory Filings
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or meeting materials, but rather serves as a formal regulatory notice of a corporate action. Given it is a specific regulatory announcement that does not fit into the other categories like dividend or share issuance, it is classified as a general regulatory filing.
2019-12-13 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Medifron DBT Co., Ltd., covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-13 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company Medifron DBT, covering the period from January 1, 2019, to June 30, 2019. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-13 Korean
투자판단관련주요경영사항(기술 도입계약 체결)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KRX) titled 'Investment Judgment Related Major Management Matters' (투자판단 관련 주요경영사항). It details a technology licensing agreement (기술 도입계약) between Medifron and Seoul National University. Since this is a specific regulatory disclosure regarding a material business event (licensing agreement) that does not fit into categories like M&A, financial reports, or share transactions, it falls under the general regulatory filing category.
2019-07-09 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the previous and new representatives, the reason for the change, the date of the board resolution, and the professional background of the new appointee. This falls directly under the category of board/management changes.
2019-07-02 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Medifron DBT' covering the period from January 1, 2019, to March 31, 2019. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.